Palatin Technologies Company

Palatin Technologies, a biopharmaceutical company, develops targeted receptor specific peptide therapeutics for the treatment of diseases.
Technology: Cancer
Industry: Sexual Healthcare
Headquarters: Cranbury, New Jersey, United States
Founded Date: 1986
Employees Number: 11-50
Funding Status: IPO
Total Funding: $104 000 000
Estimated Revenue: Less than $1M
Last Funding Date: 2016-12-08
Last Funding Type: Post-IPO Equity

Visit Website
info@palatin.com
http://twitter.com/PalatinTech
Register and Claim Ownership